Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
West German Study Group
Seagen Inc.
Ain Shams University
Canadian Cancer Trials Group
Canadian Cancer Trials Group
Novartis
GBG Forschungs GmbH
University College, London
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hamamatsu University
Bristol-Myers Squibb